Advertisement Dr Reddy's introduces generic version of Geodon in US - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Dr Reddy’s introduces generic version of Geodon in US

Dr Reddy's Laboratories has introduced a bioequivalent generic version of Geodon, Ziprasidone Hydrochloride Capsules, in the US.

The company’s Ziprasidone Hydrochloride Capsules in 20mg, 40mg, 60mg and 80mg strengths are available in 60 count bottle size.

The United States Food & Drug Administration (USFDA) approved Dr Reddy’s ANDA for Ziprasidone Hydrochloride Capsules.

The Geodon brand had US sales of approximately $1.34bn for the recent twelve months ending December 2011 according to IMS Health.

Dr Reddy’s offers a portfolio of products and services including APls, custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs.